Novel Chemerin GPCR agonist OK-113 exhibits anti-inflammatory activity in DED mouse model Aug. 30, 2019
Acurx completes multiple-ascending-dose phase I study of ACX-362E for C. difficile infection Aug. 29, 2019
Immunicum reports phase II data on ilixadencel with sunitinib in metastatic renal cell carcinoma Aug. 29, 2019
Spider silk and iron oxide nanoparticles show promise for theranostic cancer applications Aug. 29, 2019
RSS